Net Assets for Quest Diagnostics (DGX)
According to Quest Diagnostics's latest reported financial statements, the company's latest reported net assets is $7.37B USD. Net assets — also called stockholders' equity — equal total assets minus total liabilities. They represent the residual claim of shareholders on the company's assets and roughly track book value over time.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingNet AssetsSwitch metric
Latest period
$7.37B
YoY change
+5.8%
5Y CAGR
+1.2%
Peak year (2025)
$7.17B
Latest annual
$7.17B
Net Assets history chart for Quest Diagnostics (DGX) from 1996 to 2025
Net Assets history table for Quest Diagnostics (DGX) from 1996 to 2025
| Fiscal year | Period ended | Reported | Net Assets | YoY |
|---|---|---|---|---|
| 2025 | $7.17B | +5.8% | ||
| 2024 | $6.78B | +7.5% | ||
| 2023 | $6.31B | +7.0% | ||
| 2022 | $5.89B | -8.6% | ||
| 2021 | $6.44B | -4.7% | ||
| 2020 | $6.76B | +19.8% | ||
| 2019 | $5.64B | +8.1% | ||
| 2018 | $5.22B | +6.0% | ||
| 2017 | $4.92B | +6.3% | ||
| 2016 | $4.63B | -1.2% | ||
| 2015 | $4.68B | +8.9% | ||
| 2014 | $4.30B | +8.9% | ||
| 2013 | $3.95B | -5.2% | ||
| 2012 | $4.16B | +12.7% | ||
| 2011 | $3.69B | -8.4% | ||
| 2010 | $4.03B | +1.1% | ||
| 2009 | $3.99B | +10.7% | ||
| 2008 | $3.60B | +8.4% | ||
| 2007 | $3.32B | +10.1% | ||
| 2006 | $3.02B | +9.3% | ||
| 2005 | $2.76B | +20.7% | ||
| 2004 | $2.29B | -4.4% | ||
| 2003 | $2.39B | +35.4% | ||
| 2002 | $1.77B | +32.4% | ||
| 2001 | $1.34B | +29.5% | ||
| 2000 | $1.03B | +19.5% | ||
| 1999 | $863.10M | +52.0% | ||
| 1998 | $567.90M | +4.8% | ||
| 1997 | $541.70M | +0.6% | ||
| 1996 | $538.72M | — |
Net Assets values are taken from Quest Diagnostics's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, Quest Diagnostics (DGX) reported net assets of $7.17B – grew 5.8% year-over-year.
Over 2020–2025 (5 years), Quest Diagnostics net assets expanded at a +1.2% compound annual rate, sustaining 3 straight years of year-over-year growth.
The dataset's maximum net assets sits at $7.17B (2025); the minimum reading of $538.72M dates to 1996.
Among 8 Healthcare peers, Quest Diagnostics (DGX) ranks 8th; the peer median for net assets is $50.64B.
Quest Diagnostics Net Assets by Year
Quest Diagnostics Net Assets 2025: $7.17B
Quest Diagnostics net assets in 2025 was $7.17B, grew 5.8% from 2024. This figure represents the highest annual value in the available history.
Quest Diagnostics Net Assets 2024: $6.78B
Quest Diagnostics net assets in 2024 was $6.78B, grew 7.5% from 2023.
Quest Diagnostics Net Assets 2023: $6.31B
Quest Diagnostics net assets in 2023 was $6.31B, grew 7.0% from 2022.
Quest Diagnostics Net Assets 2022: $5.89B
Quest Diagnostics net assets in 2022 was $5.89B, declined 8.6% below 2021.
Quest Diagnostics Net Assets 2021: $6.44B
Quest Diagnostics net assets in 2021 was $6.44B.
See more financial history for Quest Diagnostics (DGX).
Sector peers — Net Assets
Companies in the same sector as Quest Diagnostics, ranked by their latest net assets.
| Company | Net Assets | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $194.05B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $94.11B | Healthcare |
| Johnson & Johnson (JNJ) | $81.54B | Healthcare |
| Merck & Co., Inc. (MRK) | $52.61B | Healthcare |
| AstraZeneca PLC (AZN) | $48.67B | Healthcare |
| Eli Lilly and Company (LLY) | $26.54B | Healthcare |
| Amgen Inc. (AMGN) | $8.66B | Healthcare |
| AbbVie Inc. (ABBV) | -$3.27B | Healthcare |
Frequently asked questions
What is Quest Diagnostics's net assets?
- Latest reported net assets for Quest Diagnostics (DGX) is $7.37B (period ending March 31, 2026).
How has Quest Diagnostics net assets changed year-over-year?
- Quest Diagnostics (DGX) net assets changed +5.8% year-over-year on the latest annual filing.
What is the long-term growth rate of Quest Diagnostics net assets?
- Quest Diagnostics (DGX) net assets compound annual growth rate is +1.2% over the most recent 5 years available.
When did Quest Diagnostics net assets hit its highest annual value?
- Quest Diagnostics net assets reached its highest annual value of $7.17B in 2025.
What was Quest Diagnostics net assets in 2024?
- Quest Diagnostics (DGX) net assets in 2024 was $6.78B.
What was Quest Diagnostics net assets in 2025?
- Quest Diagnostics (DGX) net assets in 2025 was $7.17B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
DGX Overview
Company profile, financial tools, and key metrics
DGX Revenue Counter
Earns $357.62 every second. See per minute, hour, and day.
DGX Earnings Counter
Earns $32.47 per second net profit. See per minute, hour, and day.
DGX Economic Scale
Exceeds Monaco's GDP. Compare with world economies.
DGX What If Invested
What if you had invested $1,000? See historical returns from any date.
DGX How It Makes Money
Discover visual breakdown of $11.28B in revenue — where it comes from and where it goes.
DGX Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
DGX Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
DGX Daily Price Character
Steady · 50.6% historical win rate (green days). Streaks & record days.
DGX Buybacks
2.09% TTM buyback yield. Shareholder yield & SBC comparison.
DGX Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.
DGX Dividend Profile
Yield: 1.72%. Safety: 5/8. See full history.
DGX Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
DGX Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.